Buy Levofloxacin Online in Canada

Levofloxacin, the L-enantiomer of ofloxacin, was approved by the U.S. FDA in 1996 and remains among the most widely prescribed fluoroquinolones. It exhibits broad-spectrum activity against many gram‑positive and gram‑negative organisms and features high oral bioavailability with extensive tissue penetration.

What Levofloxacin is (brief)

Levofloxacin is an oral and parenteral fluoroquinolone antibiotic. It inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication. It is active across a wide range of pathogens in community and hospital settings.

What it is used for (moderate)

Levofloxacin is used for acute bacterial sinusitis, community‑acquired pneumonia, chronic bronchitis, skin and soft tissue infections, urinary tract infections, and certain intra‑abdominal infections. It may be chosen when coverage against gram‑negative enteric organisms or resistant strains is required, or when patient tolerability and convenient dosing are priorities.

Contraindications and precautions (detailed — this is the focus)

Contraindications include known hypersensitivity to levofloxacin or other quinolones, and use is generally avoided in pregnancy, lactation, and children under 18 years. A history of tendon disorders related to fluoroquinolone therapy warrants caution or avoidance. In patients with myasthenia gravis, fluoroquinolones may exacerbate weakness and are generally discouraged. Prolonged QT intervals or electrolyte disturbances (hypokalemia, hypomagnesemia) heighten arrhythmia risk; avoid coadministration with other QT‑prolonging drugs.

Warnings emphasize tendonitis and tendon rupture, particularly in older adults and those on corticosteroids. CNS adverse events (dizziness, confusion, seizures) may occur, especially in patients with preexisting CNS disorders or severe renal impairment. Renal dose adjustment is required for reduced creatinine clearance; hepatic impairment warrants caution due to potential transaminase elevations. Use is generally avoided during early pregnancy and in lactation; alternative agents should be considered when feasible. Avoid concomitant antacids, sucralfate, iron, calcium, magnesium, or zinc, as these chelate levofloxacin and reduce absorption; separate dosing by at least 2 hours before or 4 hours after the antibiotic.

Side effects by frequency (detailed)

Very common (>10%): nausea, diarrhea, and headache.

Common (1–10%): dizziness, insomnia, vomiting, abdominal pain, rash, photosensitivity, taste disturbance.

Uncommon (0.1–1%): tendonitis or tendon rupture (especially Achilles), peripheral neuropathy or CNS effects (agitation, tremor, confusion), hypoglycemia or hyperglycemia, elevated liver enzymes, QT prolongation on ECG, hypersensitivity reactions.

Rare (<0.1%): Stevens–Johnson/Erythema multiforme, hepatotoxicity with jaundice, anaphylaxis, severe cutaneous reactions, blood dyscrasias, seizures in susceptible individuals.

Interactions with other substances (detailed)

Absorption is impaired by concomitant ingestion of divalent or trivalent cations; space doses of antacids containing aluminum or magnesium, calcium, iron, zinc, and sucralfate by at least 2 hours before or after levofloxacin. Theophylline, cyclosporine, and certain oral anticoagulants (e.g., warfarin) may exhibit altered levels or enhanced effects; monitor clinically and adjust as needed. QT‑prolonging drugs (including certain antiarrhythmics, macrolides, and antipsychotics) heighten arrhythmia risk, particularly with electrolyte disturbances. NSAIDs can increase CNS stimulation or seizure risk. Corticosteroid use elevates the risk of tendon injury; exercise caution with strenuous activity.